Learn More
Medchemexpress LLC TMP195 | 1314891-22-9 | 99.8% | 456.42 | 250 MG

Supplier: Medchemexpress LLC 250MGHY18361
TMP195 is a selective class IIa histone deacetylase (HDAC) inhibitor. It has reported Ki values of 59, 60, 26, and 15 nM for HDAC4, HDAC5, HDAC7, and HDAC9, respectively. It is intended for research use only and not for sale to patients.
- Selective class IIa HDAC inhibitor.
- Blocks the accumulation of CCL2 protein in monocyte-derived macrophage differentiation cultures.
- Significantly increases CCL1 protein secretion by monocytes.
- Occupies the acetyllysine-binding site of class IIa HDACs.
- Alters the tumor microenvironment, reducing tumor burden and pulmonary metastases by modulating macrophage phenotypes in vivo.
- Induces recruitment and differentiation of highly phagocytic and stimulatory macrophages within tumors in vivo.
- Combining with chemotherapy regimens or T-cell checkpoint blockade enhances the durability of tumor reduction in vivo.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.